People

Name Vorlová Barbora
Position Ph.D. Student
Barbora Vorlová

Barbora Vorlová

Ph.D. Student


Proteases of Human Pathogens
Institute of Organic Chemistry and Biochemistry ASCR, v.v.i.
Flemingovo nam. 2, CZ-166 10 Prague 6, Czech Republic

Phone: (+420) 220 183 241
Fax: (+420) 220 183 578

 
Education
since 2013 Ph.D. student in Biochemistry and Pathobiochemistry, First Faculty of Medicine, Charles University, Prague, Czech Republic. Ph.D. thesis "Biological Function of Glutamate Carboxypeptidase II and Utilisation of Expression of this Protein for Targeted Treatment of Cancer" under supervision of Dr. Pavel Šácha at the Institute of Organic Chemistry and Biochemistry AS CR, Prague.
2010-2013 M.Sc. in Biochemistry, Faculty of Science, Charles University, Prague, Czech Republic. Diploma thesis "Inhibitors of Mouse Serine Racemase" under supervision of Dr. Jan Konvalinka at the Institute of Organic Chemistry and Biochemistry AS CR, Prague.
2011-2012 M.Sc. in Molecular Medicine, Cranfield University, Cranfield, United Kingdom. Thesis "Epigenetic control of human macrophage differentiation" performed in Epinova DPU, GlaxoSmithKline, Stevenage, United Kingdom.
2007-2010 B.Sc. in Biochemistry, Faculty of Science, Charles University, Prague, Czech Republic. Bachelor thesis "Analysis of Serine Racemase Expression in the CNS of Epileptic Patients" under supervision of Dr. Jan Konvalinka at the Institute of Organic Chemistry and Biochemistry AS CR, Prague.
 
Experience
2012 Epinova DPU, GlaxoSmithKline, Stevenage, United Kingdom.
 
Courses
2013 Biological Mass Spectrometry, The 23rd Jyväskylä Summer School, University of Jyväskylä, Jyväskylä, Finland.
2011 School of Molecular Biotechnologies, Palacký University Olomouc and Contipro Group s.r.o, Czech Republic.
2010 Summer School of Protein Engineering, Masaryk University, Czech Republic.
 
Awards
2013 The Best Student Prize for The MSc in Molecular Medicine for 2013.
 
Research interests
  • biological role of GCPII
  • cancer biology
  • targeted drug delivery for cancer therapy